Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Dr. Low Chung Min, Consultant Geriatrician and Physician, presents
"Beyond the Golden Years: Managing Shingles Risk in Older Adults",
a focused session on clinical approaches to shingles in elderly patients.
The webinar addresses vaccine considerations, comorbidities, and
prevention practices relevant to Malaysia’s ageing population.
Shingrix (zoster vaccine recombinant, adjuvanted) Safety Information1:
Contraindication:
Hypersensitivity to the active substances or to any component of the vaccine.
Very common adverse events include headache, gastrointestinal symptoms (including nausea, vomiting, diarrhea and/or abdominal pain), myalgia, injection site reactions (such as pain, redness, swelling), fatigue, chills, fever.
Before prescribing, please refer to the full prescribing information available here.
Reference:
- Shingrix Prescribing Information
Trade marks are owned by or licensed to the GSK group of companies.
PM-MY-SGX-WCNT-250008 11/25
